Amnon Hoffman

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Topics

Breast Cancer Cells

Structure Activity Relationship

Top Venues

Pharmaceuticals (Basel, Switzerland)

Angewandte Chemie (International ed. in English)

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Majdi Saleem Naamneh, Tatjana Momic, Michal Klazas, Julius Grosche, Johannes Andreas Eble, Cezary Marcinkiewicz, Netaly Khazanov, Hanoch Senderowitz, Amnon Hoffman, Chaim Gilon, Jehoshua Katzhendler, Ephraim Yavin
Structure-Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities. Pharmaceuticals (Basel, Switzerland) 17 (5) (2024)
Majdi Saleem Naamneh, Tatjana Momic, Michal Klazas, Julius Grosche, Johannes Andreas Eble, Cezary Marcinkiewicz, Netaly Khazanov, Hanoch Senderowitz, Amnon Hoffman, Chaim Gilon, Jehoshua Katzhendler, Ephraim Yavin
Structure-Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities. Pharmaceuticals (Basel, Switzerland) 17 (5) (2024)
Shira Merzbach, Amnon Hoffman, Ephraim Yavin, Chaim Gilon, Radgonde Amer
Development of Clarstatin, a Novel Drug Lead for the Therapy of Autoimmune Uveitis. Pharmaceutics 16 (6) (2024)
Tovi Shapira-Furman, Ayala Bar-Hai, Amnon Hoffman, Abraham Avi J Domb
The Synthesis of SNAC Phenolate Salts and the Effect on Oral Bioavailability of Semaglutide. Molecules (Basel, Switzerland) 29 (16) (2024)
Shira Merzbach, Amnon Hoffman, Ephraim Yavin, Chaim Gilon, Radgonde Amer
Development of Clarstatin, a Novel Drug Lead for the Therapy of Autoimmune Uveitis. Pharmaceutics 16 (6) (2024)
Jeetendra Kumar Nag, Hodaya Malka, Shoshana Sedley, Priyanga Appasamy, Tatyana Rudina, Tgst Levi, Amnon Hoffman, Chaim Gilon, Beatrice Uziely, Rachel Bar-Shavit
PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design. Molecular cancer therapeutics 21 (9) (2022)
Andreas F B Räder, Michael Weinmüller, Florian Reichart, Adi Schumacher-Klinger, Shira Merzbach, Chaim Gilon, Amnon Hoffman, Horst Kessler
Orally Active Peptides: Is There a Magic Bullet? Angewandte Chemie (International ed. in English) 57 (44) (2018)